文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020.

作者信息

Aggarwal Rahul, Chiu Nicholas, Libby Peter, Boden William E, Bhatt Deepak L

机构信息

Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

出版信息

JAMA. 2023 Jul 3;330(1):80-82. doi: 10.1001/jama.2023.8646.

DOI:10.1001/jama.2023.8646
PMID:37395777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10318472/
Abstract
摘要

相似文献

[1]
Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020.

JAMA. 2023-7-3

[2]
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.

J Clin Lipidol. 2015

[3]
A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.

Indian Heart J. 2003

[4]
Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.

Metabolism. 2004-4

[5]
Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.

JAMA Cardiol. 2020-1-1

[6]
Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.

Metab Syndr Relat Disord. 2019-2-5

[7]
Summaries for patients: Are abnormal lipid levels harmful in young adults?

Ann Intern Med. 2010-8-3

[8]
Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.

Am J Cardiol. 2016-9-15

[9]
Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults.

J Clin Lipidol. 2014

[10]
Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.

J Clin Lipidol. 2012-5-22

引用本文的文献

[1]
Quantifying Patient Preferences About Features of Nonstatin Lipid-Lowering Therapies: A Discrete Choice Experiment in the United States.

Circ Cardiovasc Qual Outcomes. 2025-7-11

[2]
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population.

Am J Prev Cardiol. 2025-3-8

[3]
Targeting Lysophosphatidic Acid Ameliorates Dyslipidemia in Familial Hypercholesterolemia.

Research (Wash D C). 2023-2-27

[4]
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Circulation. 2025-2-25

[5]
Atherogenic lipid profile in patients with statin treatment after acute coronary syndrome: a real-world analysis from Chinese cardiovascular association database.

Lipids Health Dis. 2024-8-28

[6]
Low-Density Lipoprotein Cholesterol Testing Following Myocardial Infarction Hospitalization Among Medicare Beneficiaries.

JACC Adv. 2023-12-8

[7]
Temporal trends and racial/ethnic- and sex-differences in LDL cholesterol control among US adults with self-reported atherosclerotic cardiovascular disease.

Am J Prev Cardiol. 2024-4-15

[8]
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.

Circulation. 2024-2-20

[9]
Fixed Combination for the Treatment of Dyslipidaemia.

Curr Atheroscler Rep. 2023-10

本文引用的文献

[1]
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.

Diabetes Obes Metab. 2023-6

[2]
Contemporary National Patterns of Eligibility and Use of Novel Lipid-Lowering Therapies in the United States.

J Am Heart Assoc. 2022-9-20

[3]
Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007-2018.

JAMA. 2022-8-23

[4]
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.

Eur Heart J. 2020-1-1

[5]
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation. 2018-11-10

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索